CERO

0.00964.00%

CERO

0.00964.00%

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

StockTitan

Apr 13, 2026 at 11:15 PM

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

Login to unlock94characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

StockTitan

Apr 13, 2026 at 11:15 PM

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

Login to unlock94characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.